Regulatory News
Monday, April 18, 2016
BRIEF-Geovax says MVA-VLP vaccine vector has proven safe in multiple human clinical trials
* Geovax Labs inc says "vaccine construction is progressing
rapidly" and we expect to initiate animal studies next month
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment